Abortion Pill Order Threatens FDA’s Power Over Drug Safety

Professor Wendy Parmet comments on a federal appeals court’s decision to overturn the Food and Drug Administration’s (FDA) approval of the drug mifepristone used in medication abortions. “This is not a decision that seems to have very much respect for either the FDA’s expertise or the scientific evidence,” says Parmet in Bloomberg Law.